Marcelo Garrido
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers 44
- Colorectal Cancer Treatments and Studies 23
- Pancreatic and Hepatic Oncology Research 18
- Hepatology top 0.5%
- Pulmonary and Respiratory Medicine top 0.2%
- Gastric Cancer Management and Outcomes 53
- Lung Cancer Treatments and Mutations 12
- Gastroenterology top 1%
- Gastrointestinal Tumor Research and Treatment 14
- Immunology top 2%
-
- Esophageal Cancer Research and Treatment 25
-
- Cancer Genomics and Diagnostics 13
- Co-authors
- Mary J. FidlerPaul BaasJosé Luis Perez‐GraciaGilberto de CastroEnriqueta FelipCatherine Dubos ArvisMargarita MajemRoy S. Herbst
- Journals
- Journal of Clinical Oncology (33 papers)Annals of Oncology (21 papers)International Journal of Molecular Sciences (4 papers)
- Partner nations
- ChileUnited StatesSouth Korea
In The Last Decade
Marcelo Garrido
130 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 6.3k
- Hepatology 1.1k
- Pulmonary and Respiratory Medicine 4.3k
- Gastroenterology 385
- Immunology 1.5k
Countries citing papers authored by Marcelo Garrido
This map shows the geographic impact of Marcelo Garrido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcelo Garrido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcelo Garrido more than expected).
Fields of papers citing papers by Marcelo Garrido
This network shows the impact of papers produced by Marcelo Garrido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcelo Garrido. The network helps show where Marcelo Garrido may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marcelo Garrido, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 31 | |
| 9 | 2022 | 55 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 3 | |
| 13 | 2020 | 25 | |
| 14 | 2020 | 14 | |
| 15 | 2020 | 11 | |
| 16 | Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trialbreakdown → | 2019 | 1300 |
| 17 | Participación de las madres en el cuidado de los recién nacidos internados en un servicio de neonatología que aplica el modelo de maternidad centrada en la Familia | 2011 | 0 |
| 18 | 2009 | 18 | |
| 19 | 2008 | 3 | |
| 20 | 1998 | 278 |
About Marcelo Garrido
Marcelo Garrido is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 139 papers that have together received 9.3k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (53 papers), Cancer Immunotherapy and Biomarkers (44 papers), Esophageal Cancer Research and Treatment (25 papers), Colorectal Cancer Treatments and Studies (23 papers), Pancreatic and Hepatic Oncology Research (18 papers), Gastrointestinal Tumor Research and Treatment (14 papers), Cancer Genomics and Diagnostics (13 papers) and Lung Cancer Treatments and Mutations (12 papers). The work is most often cited by research in Oncology (6.3k citations), Hepatology (1.1k citations) and Pulmonary and Respiratory Medicine (4.3k citations). Marcelo Garrido has collaborated with scholars based in Chile, United States and South Korea. Frequent co-authors include Mary J. Fidler, Paul Baas, José Luis Perez‐Gracia, Gilberto de Castro, Enriqueta Felip, Catherine Dubos Arvis, Margarita Majem, Roy S. Herbst, Joo-Hang Kim and Edward B. Garon. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Molecular Sciences, Cancer Research and Pediatric Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.